Meanwhile, Zhu and colleagues revealed that CD93 was associated with immune subtypes characterized by a distinct tumor immune microenvironment and patient prognosis in stomach adenocarcinoma (STAD) (11). This evidence concerns the gene CD93 and gastric adenocarcinoma.